1. Changes To MEP

The following additions of new sections and updates to existing sections have been made to the MEP from August 2023 – June 2024.
NEW SECTIONS
July 2023
2.5.7 CLINICAL AUDIT

This section provides information on what a clinical audit is and why it is important. Also included is signposting to how to conduct a clinical audit and examples of audits templates.

July 2023
3.3.18 SELF-CHECKING PRESCRIPTIONS

Includes information on what self-checking is and an outline of points to consider before self-checking to limit errors occurring, if the pharmacists think it is deemed necessary to conduct self-checking.

UPDATED SECTIONS
February 2024
3.3.8 ADMINISTRATION

Updated section 3.3.8 Administration to include details of the new information detailed in section 3.3.16 Prescribing and dispensing/supply/administration by the same person.

January 2024
3.3.16 PRESCRIBING AND DISPENSING BY THE SAME PERSON

Updated the section title to ‘Prescribing and dispensing/supply/administration by the same person’. Included new information from the joint position statement by RPS and RCN and signposted to new guidance on safely conducting prescribing and dispensing/supply/administration by the same person.

January 2024
3.3.14 PRESCRIBER TYPES AND PRESCRIBING RESTRICTIONS

Information added in response to legislation change, which allows certain controlled drugs to be prescribed by paramedic independent prescribers (advanced paramedics) and therapeutic radiographer independent prescribers.

October 2023
3.3.11 PREGNANCY PREVENTION PROGRAMMES

Updated section on Valproate PPP to include information new legislation and publication of MHRA guidance on full pack dispensing of valproate containing medicines.

July 2023
7 APPENDICES

Reproduced GPhC Standards and Guidance in MEP updated in line with updates made by GPhC www.pharmacyregulation.org.

July 2023
2.1.4 STANDARDS AND GUIDANCE

Update information on the general topics RPS guidance covers.

Includes reference to the RPS and GPhC joint statement “Using standards to help provide safe and effective care for members of the public”.

July 2023
2.2.2 DEVELOPMENT FRAMEWORKS AND RECOGNITION

Updated details on the RPS Core Advanced Pharmacist Curriculum.

July 2023
2.2.3 PHARMACIST PRESCRIBING

Information on the RPS Expanding Prescribing Scope of Practice guidance.

July 2023
2.3.1 PHARMACISTS IN RESEARCH

Signposting to RPS Research and Evaluation guides on RPS website.

July 2023
2.5.2 CULTURE AND PATIENT SAFETY INCIDENTS

Updated information on the Just Culture Guide.

July 2023
2.5.5 HANDLING DISPENSING ERRORS

Includes details and signposting to information on the new legal defence for criminal offences relating to inadvertent preparation or dispensing errors by registered pharmacy professionals to professionals working in hospitals and other pharmacy services (e.g. in prisons and care homes) (The Pharmacy (Preparation and Dispensing Errors – Hospital and Other Pharmacy Services) Order 2022).

July 2023
2.6.5 CLINICAL CHECK

Updated Further Reading section with additional resources.

July 2023
3.2.4 CODEINE AND DIHYDROCODEINE

Importance of pharmacists and pharmacy teams asking appropriate questions to help decide if referral is appropriate to manage long term pain treatment.

July 2023
3.3.3 FAXED PRESCRIPTIONS

Updated section title to “Faxed and Digital copies of prescriptions”. Includes information to consider when supplying against digital copies of prescriptions.

July 2023
3.3.9 PATIENT SPECIFIC DIRECTIONS AND ADMINISTRATIONS, SALE AND SUPPLY IN HOSPITALS AND OTHER SETTINGS

Updated section with signposting to SPS guidance on PSDs and removal of guidance on verbal/telephoned requests to administer medicines.

July 2023
3.5.2 THE VETERINARY CASCADE

Added reference to the FAQ "Can I advise that a client use over the counter human medicines for their animal?" from the Royal College of Veterinary Surgeons website.

July 2023
3.5.5 WHOLESALE VETERINARY MEDICINES AND TEMPORARY SUPPLY SHORTAGES

Included a requirement to hold a WDA to wholesale human medicines for veterinary use under the cascade.

July 2023
3.6.7 PRESCRIPTION REQUIREMENTS FOR SCHEDULE 2 AND 3 CONTROLLED DRUGS

Prescriber’s address and Address of Patient – updated advice confirmed from Home Office that the use of PO Box is acceptable.

Signposting to the RPS support alert titled “Clarification on validity period of Controlled Drug Prescriptions “to the Further Reading section.

Further clarification and an example on instalment dispensing using the Home Office approved wording.

July 2023
3.6.13 CANNABIS AND CANNABIS-BASED PRODUCTS

Misprint in print MEP 45 (July 2022) stated the legal category of Nabilone as "POM", this has been corrected in MEP 46 (July 2023) to state the legal category of Nabilone as "Schedule 2 CD".

July 2023
4 THE RESPONSIBLE PHARMACIST

Information on the recent change in pharmacy legislation - Pharmacy (Responsible Pharmacists, Superintendent Pharmacists etc.) Order 2022 and the role of the regulators GPhC and PSNI in relation to this change.

REMOVED SECTIONS
No sections have been removed.